Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Clinical trial NCT05754528 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05754528
- Sponsor
- Ottawa Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2025-11-25
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.